002252.SZShanghai RAAS Blood Products Co., Ltd.
Oct 15, 2026 — National Plasma Station Quot
Chart by TradingViewThe schedule
- Thu15Oct
- Tue27Oct
- Thu10Dec
- Thu15Apr
Resolved
- Fri28Aug
MIXED
The company matched earnings estimates with no significant beat or miss. However, the stock remained flat due to broader market conditions and lack of clear directional catalysts. The financials showed severe YoY revenue contraction and declining net income, which overshadowed the neutral earnings report, leading to a mixed price reaction.
Shanghai RAAS reports 1H 2026 financials against a backdrop of severe YoY revenue contraction (-24.75%) and declining net income (-44.21%).